Absence of elevated anti-α-synuclein and anti-EBV latent membrane protein antibodies in PD

Neurology

Volumn 58, Issue 9, 2002, Pages 1435-1436

  Woulfe, John M ^a   Duke, R ^a   Middeldorp, J M ^a   Stevens, S ^a   Vervoort, M ^a   Hashimoto, M ^a   Masliah, E ^a   Chan, P ^a   Di Monte, D A ^a   Langston, J W ^a   Petzinger, G ^a   Hoogendoorn, H ^a   Munoz, D G ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; LATENT MEMBRANE PROTEIN 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE COURSE; EPSTEIN BARR VIRUS; HUMAN; IMMUNE RESPONSE; LATENT VIRUS INFECTION; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0037076503     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.58.9.1435     Document Type: Article

References (7)

1. Monoclonal anti-bodies against Epstein-Barr virus cross-react with a-synuclein in human brain
2. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus
3. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases
4. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
5. Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR
6. Reduced levels of amyloid β-peptide antibody in Alzheimer disease
7. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse